Peptide record

TPDB10383

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10383
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLPAVIRVAANVLPTVFCAISKKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C119H198N30O28S2
DEQGHMWY
AV
2561.19
9.92
3
0
14
+3
-0.54
1.279
130.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.05
5
Residue Composition
number
4
A
1
R
1
N
0
D
2
C
0
E
0
Q
0
G
0
H
2
I
2
L
2
K
0
M
2
F
2
P
1
S
1
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 4 R: 1 N: 1 D: 0 C: 2 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 2 K: 2 M: 0 F: 2 P: 2 S: 1 T: 1 W: 0 Y: 0 V: 4
Chemical Descriptors
24 reviewed residue count
C119H198N30O28S2 sequence-only estimate (linear, free termini)
2561.19 sequence-only estimate (linear, free termini)
9.92 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.54 sequence-only estimate (linear, free termini)
1.279 sequence-only estimate (linear, free termini)
Evidence Records 13 records
Evidence 1 Activity

Activity

MIC
Antibacterial
50 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 2 Activity

Activity

MIC
Antibacterial
6-13 µM

Target

Staphylococcus aureus MRSA

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 3 Activity

Activity

MIC
Antibacterial
50 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 4 Activity

Activity

MIC
Antifungal
50 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 5 Activity

Activity

MIC
Antifungal
6-13 µM

Target

Staphylococcus aureus MRSA

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 6 Activity

Activity

MIC
Antifungal
50 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 7 Activity

Activity

MIC
Antiparasitic
50 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 8 Activity

Activity

MIC
Antiparasitic
6-13 µM

Target

Staphylococcus aureus MRSA

Source & Reference

DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 9 Activity

Activity

MIC
Antiparasitic
50 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus MRSA (MIC 6-13 uM), and C. albicans (MIC 50 uM).
Evidence 10 Activity

Activity

% Hemolysis
Hemolysis
6.8 %
[Ref.22917879] It has 79.2 ± 6.8% hemolytic activity at 128 µg/mL against rabbit red blood cells

Target

rabbit red blood cells

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
J Proteomics. 2012 Oct 22 75(18):5807-5821.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 11 Activity

Activity

79% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
79% Hemolysis | 128 | µg/mL | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data. | J Proteomics | 2012
Evidence 12 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.22917879] It has 79.2 ± 6.8% hemolytic activity at 128 µg/mL against rabbit red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
J Proteomics. 2012 Oct 22 75(18):5807-5821.
Evidence 13 Hemolysis

Activity

6.8 %
% Hemolysis
[Ref.22917879] It has 79.2 ± 6.8% hemolytic activity at 128 µg/mL against rabbit red blood cells
Hemolysis

Target

rabbit red blood cells

Source & Reference

APD_complete HemoPI PD_Hemolysis
J Proteomics. 2012 Oct 22 75(18):5807-5821.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.